🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
At present, the treatment of non-squamous cell lung cancer is based on chem...
Status
Completed
Location
Avignon - Institut Sainte-Catherine
Start Date
2012-12
Trial ID
NCT01705184
Treatments Being Tested
Patients with histological proven advanced gastric cancer (including cancer...
Status
Unknown
Location
Meng Wang
Start Date
2015-01
Trial ID
NCT02381847
Treatments Being Tested
This pilot study is evaluating how well pembrolizumab and combination chemo...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-11-24
Trial ID
NCT04383743
The purpose of this study is to compare the survival and toxicity of TPC (T...
Status
Completed
Location
SunYat-senU
Start Date
2016-10-20
Trial ID
NCT02940925
Treatments Being Tested
To observe the efficacy and toxicities of post-operative (R0/R1) proton rad...
Status
Recruiting
Location
Shanghai Proton and Heavy Ion Center
Start Date
2024-05-06
Trial ID
NCT06311968
Treatments Being Tested
The present study will be a randomized, control, multicenter phase III stud...
Status
Completed
Location
Department of Medical Oncology,Cancer Center of Sun Yat-Sen University
Start Date
2012-02-21
Trial ID
NCT01528618
Treatments Being Tested
This is an open-label, parallel controlled, phase IIa exploratory study tha...
Status
Unknown
Location
Multiple Locations
Start Date
2020-07-15
Trial ID
NCT04446663
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of sequenti...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2018-01-01
Trial ID
NCT03366415
This is a phase II study of taxotere, cisplatin and irinotecan (CPT-11) use...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2001-08
Trial ID
NCT00165464
Treatments Being Tested
This is a multicenter, randomized, open-label, phase III clinical study, to...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-09-10
Trial ID
NCT07174908